Medical Robots Market by Product & Services (Instruments & Accessories, Robotic Systems, Services), Type (Surgical (General, Gynecological, Urological, Knee & Hip, Spine), Rehabilitation, Hospital, Pharmacy), End User, and Region - Global Forecasts to 2031

icon1
USD 41.7 BN
MARKET SIZE, 2030
icon2
CAGR 15.1%
(2025-2030)
icon3
480
REPORT PAGES
icon4
600
MARKET TABLES

OVERVIEW

medical-robotic-systems-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global medical robots market is projected to reach USD 41.7 billion in 2031 from USD 20.6 billion in 2026, at a CAGR of 15.1% during the forecast period. Advancements in medical robotic technologies, including AI-enabled surgical planning, image-guided navigation, robotic arms, automated medication dispensing, and rehabilitation exoskeletons, are enabling greater precision, workflow efficiency, and improved patient outcomes compared to conventional approaches. These innovations enhance clinical accuracy, reduce procedural variability, support minimally invasive care, and improve patient safety. Rising chronic disease burden, increasing geriatric population, growing surgical volumes, and the need to minimize medication errors are driving global demand for medical robots.

KEY TAKEAWAYS

  • BY REGION
    The North America medical robots market accounted for highest share in the global market in 2025.
  • BY PRODUCT
    Based on products & services, the instruments & accessories segment accounted for the largest share of the medical robots market in 2025.
  • BY TYPE
    By type, the surgical robotic systems segment is estimated to account for the largest market share during the forecast period.
  • BY END USER
    Based on end user, the hospitals & clinics segment is estimated to account the highest share of the surgical robots market during the forecast period.
  • Competitive Landscape
    Intuitive Surgical and Medtronic Plc were recognized as star players due to their established strong product portfolio.
  • Competitive Landscape
    ARxIUM and Relay Robotics, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The global medical robots market is witnessing steady growth, driven by several key factors. The rising burden of chronic diseases, aging populations, increasing surgical volumes, and growing demand for minimally invasive procedures are accelerating the adoption of robotic-assisted technologies across healthcare settings. In addition, advancements in surgical robotics, rehabilitation robots, hospital automation, pharmacy robotics, and non-invasive radiosurgery systems, along with innovations in AI-enabled planning, image-guided navigation, workflow automation, and real-time data integration, are improving procedural precision, operational efficiency, patient safety, and scalability of robotic healthcare delivery worldwide.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The medical robots market is undergoing major shifts driven by rapid technological advancement, expanding clinical applications, and increasing pressure on healthcare systems to improve efficiency, safety, and patient outcomes. The integration of robotics with AI-enabled planning, advanced imaging, navigation systems, automation software, and real-time data analytics is enhancing precision across surgical procedures, rehabilitation therapy, radiosurgery, pharmacy automation, and hospital workflow management. The emergence of compact, modular, and application-specific robotic systems is expanding adoption beyond large tertiary hospitals to ambulatory surgery centers, rehabilitation facilities, pharmacies, and specialty care settings. Advancements in robotic-assisted surgery, medication dispensing automation, rehabilitation exoskeletons, autonomous hospital logistics, and non-invasive radiosurgery are helping providers reduce procedural variability, minimize medication errors, improve recovery outcomes, and optimize staff productivity, while competitive disruption is pushing the market toward service-based models, recurring consumables, software-enabled platforms, remote support, and training ecosystems.

medical-robotic-systems-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing geriatric population with chronic diseases
  • Technological advancements in medical robotics
RESTRAINTS
Impact
Level
  • High cost of medical robotic systems
  • Stringent regulatory requirements and delays in product approvals
OPPORTUNITIES
Impact
Level
  • High growth opportunities in emerging economies
  • Increased use of robotics in novel applications
CHALLENGES
Impact
Level
  • Need to ensure patient and provider acceptance

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Technological advancements in medical robotics

Technological advancements in medical robotics are a key driver of market growth, as they are improving procedural precision, clinical efficiency, safety, and workflow automation across healthcare settings. Innovations such as AI-enabled surgical planning, image-guided navigation, advanced robotic arms, real-time data integration, haptic feedback, compact robotic platforms, automated medication dispensing, and rehabilitation exoskeletons are expanding the use of robots beyond conventional surgical applications. These technologies help hospitals and care providers reduce procedural variability, support minimally invasive interventions, improve medication accuracy, and deliver more consistent rehabilitation outcomes. For instance, in 2025, Medtronic received U.S. FDA clearance for its Hugo robotic-assisted surgery system for minimally invasive urologic procedures, including prostatectomy, nephrectomy, and cystectomy, reflecting continued innovation and regulatory progress in surgical robotics.

Restraint: High cost of medical robotic systems

The high cost of medical robotic systems is a major restraint limiting broader market adoption, particularly across small hospitals, ambulatory surgery centers, rehabilitation facilities, and healthcare providers in cost-sensitive markets. Medical robotic platforms often involve high upfront capital investment, along with recurring expenses related to instruments & accessories, maintenance contracts, software upgrades, staff training, and infrastructure modifications. For instance, robotic surgical platforms such as Intuitive Surgical’s da Vinci system and Stryker’s Mako robotic-arm-assisted platform require significant capital investment, in addition to recurring costs for maintenance, procedure-specific instruments, accessories, disposables, training, and software support. These high total ownership costs can make it difficult for smaller facilities to justify adoption, especially when procedure volumes are insufficient to generate a strong return on investment. As a result, despite the clinical benefits of robotic-assisted care, affordability challenges continue to restrict faster penetration of medical robots across emerging economies and lower-volume healthcare settings.

Opportunity: Increased use of robotics in novel applications

The growing use of robotics in novel applications is driving significant growth opportunities in the medical robots market, as healthcare providers increasingly deploy robots beyond traditional surgical settings. Medical robots are now being adopted in areas such as hospital logistics, pharmacy automation, rehabilitation therapy, radiosurgery, patient support, and medication delivery, enabling providers to improve workflow efficiency, reduce staff burden, minimize errors, and enhance care delivery. For example, in 2025, Swisslog Healthcare partnered with Diligent Robotics to offer Moxi autonomous delivery robots for hospital “last-mile” logistics, supporting tasks such as medication, lab sample, and supply delivery across healthcare facilities. Diligent Robotics has reported that Moxi has already been deployed in more than 25 U.S. hospitals and has completed over one million deliveries, highlighting the growing role of robotics in non-surgical healthcare applications.

Challenge: Need to ensure patient and provider acceptance

Need to ensure patient and provider acceptance remains a key challenge in the medical robots market, as successful adoption depends not only on technological performance but also on trust, usability, training, and perceived clinical value. Patients may have concerns regarding safety, reliability, outcomes, and the extent of human control in robot-assisted procedures, while healthcare providers may face challenges related to learning curves, workflow changes, operating room coordination, and confidence in using robotic platforms. Adoption is therefore closely linked to surgeon training, clinical evidence, patient education, and the ability of robotic systems to integrate smoothly into existing care pathways. For example, Intuitive offers structured da Vinci learning pathways for surgeons, residents, fellows, and operating room care teams, reflecting the importance of training and confidence-building in robotic-assisted surgery adoption. As medical robots expand into surgery, rehabilitation, pharmacy automation, and hospital logistics, building acceptance among both patients and providers will remain critical for wider market penetration

MEDICAL ROBOTS MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Surgical robotic systems and precision instruments designed for minimally invasive procedures across urology, gynecology, thoracic, and general surgery | Equipped with 3D visualization, multi-jointed instruments, and enhanced ergonomics to support highly controlled surgical maneuvers Enhance surgical precision and dexterity, reduce tissue trauma and complications, support faster patient recovery, and improve consistency and reproducibility in complex minimally invasive procedures
Orthopedic robotic platform that combines CT-based planning with robotic arm guidance for knee and hip arthroplasty | Enables surgeons to execute personalized implant alignment and bone preparation based on patient-specific anatomy Improve accuracy of implant positioning, enhance joint stability and alignment, reduce post-operative variability, and support long-term functional outcomes in joint replacement surgeries
Robotic guidance, navigation, and planning system used primarily in spine surgery | Integrates 3D planning, AI-enhanced imaging, and precise robotic guidance to support accurate screw placement and complex spinal corrections Increase accuracy in spinal instrumentation, reduce intraoperative deviations, improve surgeon control in high-risk procedures, and enhance overall safety and predictability in spine surgeries
Compact, handheld robotic-assisted platform designed for partial and total knee arthroplasty | Uses real-time intraoperative mapping to help surgeons achieve precise ligament balancing and bone reshaping without requiring preoperative CT scans Support personalized knee reconstruction, improve precision in bone preparation, reduce variability in soft-tissue balancing, and enhance workflow efficiency for outpatient and ASC environments
Multi-specialty robotic platforms that combine data analytics, navigation, and robotic guidance to optimize knee and hip arthroplasty as well as brain surgeries | Provide real-time anatomical data for personalized surgical execution Increase accuracy of implant alignment, enhance surgical decision-making through real-time data, reduce complication risks, and standardize outcomes across orthopedic and neurosurgical procedures

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The medical robots market operates within a broad and increasingly integrated ecosystem that includes robotic system manufacturers, healthcare providers, regulatory authorities, technology suppliers, software developers, training organizations, and providers of instruments, accessories, and maintenance services. Leading companies such as Intuitive Surgical, Stryker, Medtronic, Zimmer Biomet, Smith+Nephew, BD, Omnicell, Accuray, CMR Surgical, DIH Medical, and Cyberdyne develop robotic platforms and automation solutions across surgical robotics, rehabilitation robotics, pharmacy automation, hospital logistics, and non-invasive radiosurgery. Supporting components, including robotic arms, end-effectors, surgical instruments, disposable accessories, imaging and navigation systems, sensors, AI-enabled software modules, medication dispensing units, and service contracts, are critical to ensuring precision, safety, workflow efficiency, and system reliability across healthcare settings. Healthcare providers, including hospitals, ambulatory surgery centers, pharmacies, rehabilitation centers, and specialty clinics, drive adoption based on clinical demand, procedural efficiency, patient outcomes, medication safety, and operational productivity. Regulatory bodies play a central role in establishing safety, performance, clinical validation, cybersecurity, and interoperability requirements, while training institutions and service providers support user adoption, skill development, and long-term utilization of medical robotic systems.

medical-robotic-systems-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Medical Robots Market, By Product & Service

Based on products & services, the medical robots market is segmented into robotic systems, instruments & accessories, and services. The robotic systems segment is projected to witness the highest growth rate during the forecast period, supported by the increasing deployment of robotic platforms across both clinical and operational healthcare workflows. Growth in this segment is being driven by the need to improve procedural standardization, reduce human error, enhance treatment consistency, and address workforce limitations across hospitals and specialty care settings. The rising adoption of procedure-specific robotic platforms, compact systems for outpatient care, rehabilitation robots, pharmacy automation systems, and robotic radiosurgery platforms is further expanding the application base of medical robots. In addition, continued investments in next-generation robotic hardware, software-enabled control systems, remote monitoring, and integrated workflow solutions are expected to accelerate demand for robotic systems across the healthcare ecosystem.

Medical Robots Market, By Type

Based on type, the medical robots market is segmented into surgical robotic systems, rehabilitation robotic systems, radiosurgery robotic systems, hospital robotic systems, and pharmacy robotic systems. The hospital robotic systems segment is expected to register the highest CAGR during the forecast period, driven by the increasing adoption of automation across hospital workflows, including diagnostics, patient support, internal logistics, disinfection, medication transport, and clinical assistance. The growing use of diagnostic robots and imaging-integrated robotic platforms is further supporting segment growth, as hospitals increasingly focus on improving diagnostic accuracy, reducing manual workload, and enhancing workflow efficiency. In addition, rising pressure on hospitals to address staff shortages, improve patient throughput, reduce infection risks, and optimize operational productivity is accelerating the deployment of robotic systems across hospital environments. The expansion of smart hospitals and digitally connected care infrastructure is expected to further strengthen demand for hospital robotic systems over the forecast period.

Medical Robots Market, By End User

Based on end user, the medical robots market is segmented into hospitals & clinics, ambulatory surgery centers, pharmacies, rehabilitation centers, and other end users. The ambulatory surgery centers segment is projected to witness the highest growth rate during the forecast period, supported by the growing preference for outpatient surgical care and the increasing availability of robotic platforms suitable for focused, high-volume procedures. ASCs are increasingly adopting robotic-assisted technologies to improve procedural consistency, enhance surgeon control, and support faster patient turnover in cost-sensitive care settings. The segment is also benefiting from the development of smaller, more flexible, and procedure-specific robotic systems that require less infrastructure than traditional hospital-based platforms. In addition, rising investments in advanced ambulatory care infrastructure and the growing emphasis on same-day discharge models are expected to further support the adoption of medical robots across ASCs.

REGION

Asia Pacific to be fastest-growing region in global medical robots market during forecast period

The Asia Pacific region is expected to witness the highest CAGR in the medical robots market during the forecast period. The rising prevalence of chronic diseases, increasing surgical volumes, growing geriatric population, and expanding demand for minimally invasive and precision-based procedures are driving market growth across the region. Rapid adoption of advanced technologies such as surgical robots, rehabilitation robots, pharmacy automation systems, hospital robotic systems, and robotic radiosurgery platforms is further supporting market expansion. The region’s large patient pool, rising healthcare expenditure, improving hospital infrastructure, and growing disposable incomes are increasing the demand for advanced robotic healthcare solutions. Moreover, government initiatives to strengthen healthcare systems, expansion of private hospital networks, and increasing digitalization of healthcare facilities are anticipated to accelerate the growth of the Asia Pacific medical robots market.

medical-robotic-systems-market Region

MEDICAL ROBOTS MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMPANY EVALUATION MATRIX

In the medical robots market matrix, Intuitive Surgical (Star) leads with its unmatched global installed base, strong brand recognition, and comprehensive da Vinci platform ecosystem that spans instruments, accessories, training, and digital surgery solutions. CMR Surgical (Emerging Leader) is rapidly gaining traction with its versatile and cost-effective Versius robotic system, which offers modular design, improved maneuverability, and greater accessibility for hospitals and ambulatory centers.

medical-robotic-systems-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET SCOPE

REPORT METRIC DETAILS
Market Size Value in 2025 USD Billion
Revenue Forecast in 2031 USD 41.7 Billion
Growth Rate CAGR of 15.1% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Million), Volume (Million Units)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Product & Service:
    • Instruments & Accessories
    • Robotic Systems
    • Services
  • By Application:
    • General Surgery
    • Gynecological Surgery
    • Orthopedic Surgery
    • Urological Surgery
    • Neurosurgery
    • Microsurgery
    • Otological Surgery and Others
  • By End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgery Centers
  • By Region
Regional Scope North America, Asia Pacific, Europe, Latin America, and Middle East & Africa

WHAT IS IN IT FOR YOU: MEDICAL ROBOTS MARKET: GROWTH, SIZE, SHARE, AND TRENDS REPORT CONTENT GUIDE

medical-robotic-systems-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Volume Analysis Market assessment by volume (units) for surgical robots used in medical settings
  • Insights on product demand by volume
  • YOY growth (%) and demand for key categories
Company Information
  • Key players: Intuitive Surgical (US), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK) and Zimmer Biomet (US)
  • Top 3-5 players' market share analysis at APAC and European country level
Insights on revenue shifts towards emerging therapeutic applications and device innovations

RECENT DEVELOPMENTS

  • October 2025 : Zimmer Biomet (US) completed the acquisition of Monogram Technologies, Inc. (US), an AI-driven orthopedic robotics company, to expand its robotics and navigation portfolio.
  • October 2024 : CMR Surgical (UK) received U.S. FDA De Novo authorization for its Versius Surgical System for use in cholecystectomy procedures.
  • June 2024 : Medtronic’s USD 8 million asset purchase and licensing agreement with Titan Medical expands its intellectual property portfolio in soft-tissue robotics. By acquiring key technologies and design concepts, Medtronic reinforces its development pipeline for the Hugo RAS system. This strategic move strengthens its competitive position and accelerates innovation in multi-specialty robotic surgery.
  • March 2024 : The FDA’s 510(k) clearance of the da Vinci 5 system introduces Intuitive’s next-generation platform with advancements in instrumentation, imaging, system responsiveness, and surgeon ergonomics. The new system raises the bar for precision and reliability in minimally invasive soft-tissue surgery. This approval reinforces Intuitive’s market leadership and expands its technological edge in robotic surgery.

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
4
MARKET OVERVIEW
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
4.2.4
CHALLENGES
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
5
INDUSTRY TRENDS
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
 
 
 
 
 
5.1
PORTER'S FIVE FORCES ANALYSIS
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
5.2.3
TRENDS IN SURGICAL ROBOTS INDUSTRY
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2023-2025)
 
 
 
 
5.6.2
AVERAGE SELLING PRICE TREND, BY REGION (2023-2025)
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
5.7.1
IMPORT SCENARIO (HS CODE 901890)
 
 
 
 
5.7.2
EXPORT SCENARIO (HS CODE 901890)
 
 
 
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.10
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.11
CASE STUDY ANALYSIS
 
 
 
 
5.12
IMPACT OF 2025 US TARIFF – MEDICAL ROBOTS MARKET
 
 
 
 
 
 
5.12.1
INTRODUCTION
 
 
 
 
5.12.2
KEY TARIFF RATES
 
 
 
 
5.12.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.12.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
0.0.0.1
US
 
 
 
 
0.0.0.2
EUROPE
 
 
 
 
0.0.0.3
APAC
 
 
 
5.12.5
IMPACT ON END-USE INDUSTRIES
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
6.3
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
6.4
PATENT ANALYSIS
 
 
 
 
 
6.5
FUTURE APPLICATIONS
 
 
 
 
6.6
IMPACT OF AI/GEN AI ON MEDICAL ROBOTS MARKET
 
 
 
 
 
 
6.6.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
6.6.2
CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL ROBOTS MARKET
 
 
 
 
6.6.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
6.6.4
CLIENTS' READINESS TO ADOPT GENERATIVE AI IN MEDICAL ROBOTS MARKET
 
 
7
REGULATORY LANDSCAPE
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
7.2
CERTIFICATIONS, LABELING, ECO-STANDARDS
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
9
MEDICAL ROBOTS MARKET DATA, BY PRODUCT & SERVICE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME UNITS)
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
9.2
INSTRUMENTS & ACCESSORIES
 
 
 
 
9.3
ROBOTIC SYSTEMS
 
 
 
 
9.4
SERVICES
 
 
 
10
MEDICAL ROBOTS MARKET DATA, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME UNITS)
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
10.2
SURGICAL ROBOTIC SYSTEM
 
 
 
 
 
10.2.1
SOFT TISSUE SURGERY
 
 
 
 
 
10.2.1.1
GENERAL SURGERY
 
 
 
 
10.2.1.2
GYNECOLOGICAL SURGERY
 
 
 
 
10.2.1.3
UROLOGICAL SURGERY
 
 
 
 
10.2.1.4
OTHER SOFT TISSUE SURGERIES
 
 
 
10.2.2
HARD TISSUE SURGERY
 
 
 
 
 
10.2.2.1
KNEE & HIP SURGERY
 
 
 
 
10.2.2.2
SPINE SURGERY
 
 
 
 
10.2.2.3
OTHER HARD TISSUE SURGERIES
 
 
10.3
REHABILITATION ROBOTIC SYSTEMS
 
 
 
 
 
10.3.1
THERAPEUTIC ROBOTIC SYSTEMS
 
 
 
 
10.3.2
ASSISTIVE ROBOTIC SYSTEMS
 
 
 
 
10.3.3
EXOSKELETON ROBOTIC SYSTEMS
 
 
 
 
10.3.4
OTHER REHABILITATION ROBOTIC SYSTEMS
 
 
 
10.4
RADIOSURGERY ROBOTIC SYSTEMS
 
 
 
 
10.5
HOSPITAL ROBOTIC SYSTEMS
 
 
 
 
 
10.5.1
DELIVERY ROBOTIC SYSTEMS
 
 
 
 
10.5.2
TELEPRESENCE ROBOTIC SYSTEMS
 
 
 
 
10.5.3
DIAGNOSTIC ROBOTIC SYSTEMS
 
 
 
 
10.5.4
OTHER HOSPITAL ROBOTIC SYSTEMS
 
 
 
10.6
PHARMACY ROBOTIC SYSTEMS
 
 
 
 
 
10.6.1
ROBOTIC DISPENSING SYSTEMS
 
 
 
 
10.6.2
COMPOUNDING ROBOTIC SYSTEMS
 
 
 
 
10.6.3
OTHER PHARMACY ROBOTIC SYSTEMS
 
 
11
MEDICAL ROBOTS MARKET DATA, BY END USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME UNITS)
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
11.2
HOSPITALS & CLINICS
 
 
 
 
11.3
AMBULATORY SURGERY CENTERS
 
 
 
 
11.4
PHARMACIES
 
 
 
 
11.5
REHABILITATION CENTERS
 
 
 
 
11.6
OTHER END USERS
 
 
 
12
MEDICAL ROBOTS MARKET DATA, BY REGION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME UNITS)
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
12.2
NORTH AMERICA
 
 
 
 
 
12.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
12.2.2
US
 
 
 
 
12.2.3
CANADA
 
 
 
12.3
EUROPE
 
 
 
 
 
12.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
12.3.2
GERMANY
 
 
 
 
12.3.3
UK
 
 
 
 
12.3.4
FRANCE
 
 
 
 
12.3.5
ITALY
 
 
 
 
12.3.6
SPAIN
 
 
 
 
12.3.7
REST OF EUROPE
 
 
 
12.4
ASIA PACIFIC
 
 
 
 
 
12.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
12.4.2
CHINA
 
 
 
 
12.4.3
JAPAN
 
 
 
 
12.4.4
INDIA
 
 
 
 
12.4.5
AUSTRALIA
 
 
 
 
12.4.6
SOUTH KOREA
 
 
 
 
12.4.7
REST OF ASIA PACIFIC
 
 
 
12.5
LATIN AMERICA
 
 
 
 
 
12.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
12.5.2
BRAZIL
 
 
 
 
12.5.3
MEXICO
 
 
 
 
12.5.4
REST OF LATIN AMERICA
 
 
 
12.6
MIDDLE EAST & AFRICA
 
 
 
 
 
12.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
12.6.2
GCC COUNTRIES
 
 
 
 
12.6.3
REST OF MIDDLE EAST & AFRICA
 
 
13
COMPETITIVE LANDSCAPE
 
 
 
 
 
13.1
OVERVIEW
 
 
 
 
13.2
KEY PLAYERS' STRATEGIES/RIGHT TO WIN
 
 
 
 
13.3
REVENUE ANALYSIS, 2021-2025
 
 
 
 
 
13.4
MARKET SHARE ANALYSIS,
 
 
 
 
 
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
13.5.1
STARS
 
 
 
 
13.5.2
EMERGING LEADERS
 
 
 
 
13.5.3
PERVASIVE PLAYERS
 
 
 
 
13.5.4
PARTICIPANTS
 
 
 
 
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
13.5.5.1
COMPANY FOOTPRINT
 
 
 
 
13.5.5.2
REGION FOOTPRINT
 
 
 
 
13.5.5.3
PRODUCT & SERVICE FOOTPRINT
 
 
 
 
13.5.5.4
TYPE FOOTPRINT
 
 
 
 
13.5.5.5
END USER FOOTPRINT
 
 
13.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
13.6.1
PROGRESSIVE COMPANIES
 
 
 
 
13.6.2
RESPONSIVE COMPANIES
 
 
 
 
13.6.3
DYNAMIC COMPANIES
 
 
 
 
13.6.4
STARTING BLOCKS
 
 
 
 
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
13.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
13.7
COMPETITIVE SCENARIO
 
 
 
 
 
13.7.1
PRODUCT LAUNCHES
 
 
 
 
13.7.2
DEALS
 
 
 
 
13.7.3
EXPANSIONS
 
 
 
 
13.7.4
OTHER DEVELOPMENTS
 
 
 
13.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
13.9
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
14
COMPANY PROFILES
 
 
 
 
 
(BUSINESS OVERVIEW, PRODUCTS OFFERED, INDUSTRY-SPECIFIC DEVELOPMENTS FOR 2022-2025)
 
 
 
 
 
14.1
KEY PLAYERS
 
 
 
 
 
14.1.1
INTUITIVE SURGICAL, INC.
 
 
 
 
14.1.2
STRYKER
 
 
 
 
14.1.3
BECTON, DICKINSON AND COMPANY
 
 
 
 
14.1.4
MEDTRONIC
 
 
 
 
14.1.5
OMNICELL, INC.
 
 
 
 
14.1.6
ZIMMER BIOMET
 
 
 
 
14.1.7
SMITH & NEPHEW
 
 
 
 
14.1.8
EKSO BIONICS HOLDINGS, INC.
 
 
 
 
14.1.9
ARXIUM
 
 
 
 
14.1.10
ASENSUS SURGICAL US, INC. (SUBSIDIARY OF KARL STORZ SE & CO. KG)
 
 
 
 
14.1.11
RENISHAW PLC
 
 
 
 
14.1.12
ZAP SURGICAL SYSTEMS, INC.
 
 
 
 
14.1.13
KUKA SE & CO. KGAA
 
 
 
 
14.1.14
CMR SURGICAL
 
 
 
 
14.1.15
ACCURAY INCORPORATED
 
 
 
 
14.1.16
DIH MEDICAL
 
 
 
 
14.1.17
JOHNSON & JOHNSON
 
 
 
 
14.1.18
CYBERDYNE INC.
 
 
 
 
14.1.19
LIFEWARD, INC.
 
 
 
 
14.1.20
RELAY ROBOTICS
 
 
 
14.2
OTHER PLAYERS
 
 
 
 
 
14.2.1
ST ENGINEERING (AETHON, INC.)
 
 
 
 
14.2.2
XENEX DISINFECTION SERVICES INC.
 
 
 
 
14.2.3
STEREOTAXIS, INC.
 
 
 
 
14.2.4
PROCEPT BIOROBOTICS CORPORATION
 
 
 
 
14.2.5
GLOBUS MEDICAL
 
 
15
RESEARCH METHODOLOGY
 
 
 
 
 
15.1
RESEARCH DATA
 
 
 
 
 
15.1.1
SECONDARY DATA
 
 
 
 
 
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
15.1.2
PRIMARY DATA
 
 
 
 
 
15.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
15.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
15.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
15.1.2.4
KEY INDUSTRY INSIGHTS
 
 
15.2
MARKET SIZE ESTIMATION
 
 
 
 
 
15.2.1
BOTTOM-UP APPROACH
 
 
 
 
15.2.2
TOP-DOWN APPROACH
 
 
 
 
15.2.3
BASE NUMBER CALCULATION
 
 
 
15.3
MARKET FORECAST APPROACH
 
 
 
 
 
15.3.1
SUPPLY SIDE
 
 
 
 
15.3.2
DEMAND SIDE
 
 
 
15.4
DATA TRIANGULATION
 
 
 
 
15.5
FACTOR ANALYSIS
 
 
 
 
15.6
RESEARCH ASSUMPTIONS
 
 
 
 
15.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
16
APPENDIX
 
 
 
 
 
16.1
DISCUSSION GUIDE
 
 
 
 
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
 
 
 
 
16.3
CUSTOMIZATION OPTIONS
 
 
 
 
16.4
RELATED REPORTS
 
 
 
 
16.5
AUTHOR DETAILS
 
 
 
 
DISCLAIMER: MARKETSANDMARKETS' STRATEGIC ANALYSIS SERVICES ARE LIMITED PUBLICATIONS CONTAINING VALUABLE MARKET INFORMATION THAT IS PROVIDED TO A SELECT GROUP OF CUSTOMERS IN RESPONSE TO ORDERS. OUR CUSTOMERS ACKNOWLEDGE, WHEN ORDERING, THAT MARKETSANDMARK
 
 
 
 
 
MARKETSANDMARKETS DOES NOT ENDORSE ANY VENDOR, PRODUCT, OR SERVICE DEPICTED IN ITS RESEARCH PUBLICATIONS. MARKETSANDMARKETS' STRATEGIC ANALYSIS PUBLICATIONS ARE OPINIONS BASED ON ITS RESEARCH AND SHOULD NOT BE CONSTRUED AS STATEMENTS OF FACT. MARKETSANDMA
 
 
 
 
 
MARKETSANDMARKETS TAKES NO RESPONSIBILITY FOR ANY INCORRECT INFORMATION SUPPLIED TO IT BY MANUFACTURERS OR USERS.
Market Size, Volume & Forecast – USD Million
 
 
 
 

Methodology

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the medical robots market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the medical robots market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Ambulatory surgery centers (ASCs),  Minimally Invasive Robotic Association (MIRA), Clinical Robotic Surgery Association (CRSA), American Association of Healthcare Administrative Management (AAHAM), Centers for Disease Control and Prevention (CDC), American Medical Group Association (AMGA), Centers for Medicare & Medicaid Services (CMS), American Hospital Association (AHA), Expert Interviews, and MarketsandMarkets Analysis.

Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the medical robots market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.           

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global medical robots market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Breakdown of Primary Interviews

Medical Robots Market Size, and Share

Notes: C-level primaries include CEOs, CFOs, COOs, and VPs.
Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the global medical robots market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • Key players in the global medical robots market were identified through secondary research, and their global market shares were determined through primary and secondary research
  • The research methodology included the study of the annual and quarterly financial reports and regulatory filings, data books of major market players, and interviews with industry experts for detailed market insights.
  • All percentage shares, splits, and breakdowns for the global medical robots market were determined by using secondary sources and verified through primary sources.
  • All key macro indicators affecting the revenue growth of market segments and subsegments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get validated and verified quantitative and qualitative data.
  • The gathered market data was consolidated and added with detailed inputs and analysis, and presented in this report.

Medical Robots Market : Top-Down and Bottom-Up Approach

Medical Robots Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the medical robots market was split into segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Medical robots are advanced technological systems designed to assist healthcare professionals in various medical procedures, tasks, and interventions. These robots are equipped with sensors, actuators, and sophisticated control systems that enable them to perform specific functions autonomously or under the guidance of human operators.

Medical robots are utilized across different domains within healthcare, including surgery, rehabilitation, diagnostics, pharmacy automation, and patient care. They play a crucial role in enhancing precision, efficiency, and safety in medical interventions, contributing to improved patient outcomes, reduced complications, and enhanced healthcare delivery.

Key Stakeholders

  • Manufacturers of medical robots
  • Suppliers and distributors of medical robots
  • Third-party refurbishers/suppliers
  • Clinical settings
  • Educational institutions
  • Group purchasing organizations (GPOs)
  • Academic medical centers and universities
  • Corporate entities
  • Community centers
  • Government institutes
  • Market research & consulting firms
  • Contract manufacturing organizations (CMOs)
  • Venture capitalists & investors

Report Objectives

  • To define, describe, and forecast the medical robots market by product & service, type, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall medical robots market
  • To analyze the opportunities in the market for stakeholders and provide details of
    the competitive landscape for market leaders
  • To profile the key players in the market and comprehensively analyze their market shares and core competencies2
  • To forecast the size of the market segments with respect to five main regions:
    North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa
  • To track and analyze competitive developments such as product launches & approvals, acquisitions, expansions, partnerships, deployments, agreements, and collaborations in the overall medical robots market
  • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Europe medical robots market into Switzerland, Russia, and others
  • Further breakdown of the Rest of Asia Pacific medical robots market into South Korea, Singapore, and others

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Medical Robots Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Medical Robots Market

DMCA.com Protection Status